NCT05097326View on ClinicalTrials.gov

Mifepristone for Labor Induction

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 27, 2022

Primary Completion Date

April 29, 2023

Study Completion Date

April 29, 2023

Conditions
Induced Vaginal Delivery
Interventions
DRUG

Mifepristone

Mifepristone 200mg taken orally

DRUG

Misoprostol

Misoprostol 50 mcg taken orally, and may receive additional doses of misoprostol 50 - 100 mcg as needed

Trial Locations (1)

94304

Lucile Packard Children's Hospital, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER